Halozyme Therapeutics, Inc.

Halozyme Therapeutics, Inc.

122.96
USD
-7.38
(-5.66%)
3.42EPS
22.25P/E
8.93BMarket Cap
Nov 05Next Earn

Halozyme Therapeutics, Inc. Documents

Q3 FY2024 · Presentation

Halozyme Therapeutics Inc - Investor Update - Conference Call Deck · 9 pages

Read Halozyme Therapeutics, Inc.'s results firsthand

Preview the first 2 pages of this presentation
Create a free account to start reading

Full documents are included with Professional

Q3 FY2024 documents